Associations of endogenous hormones with HDL novel metrics across the menopause transition: The SWAN HDL Study.

Some of the associations linking E2 and FSH with novel HDL metrics were vulnerable to time relative to menopause onset. Whether a late initiation of hormone therapy relative to menopause could have a detrimental effect on lipid content of HDL particles should be tested in the future.